Elisabet I. Nielsen

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Collaborators (5)

Jon Ulf Hansen

Statens Serum Institut

Thomas Tängdén

Uppsala University

Vincent ARANZANA-CLIMENT

Associate Professor

University of Poitiers

Lena Friberg

Uppsala University

Anouk Muller

department of pathology erasmus university medical center rotterdam the netherlands

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Elisabet I. Nielsen

Research Interests

Explore related searches

Contact this professor

Articles (20)

Collaborators (5)

Jon Ulf Hansen

Thomas Tängdén

Vincent ARANZANA-CLIMENT

Lena Friberg

Anouk Muller

Make your next move.

Elisabet I. Nielsen

Research Interests

Explore related searches

Contact this professor

Articles (20)

An integrative and translational PKPD modelling approach to explore the combined effect of polymyxin B and minocycline against Klebsiella pneumoniae.

Short, extended and continuous infusion of β-lactams: predicted impact on target attainment and risk for toxicity in an ICU patient cohort

Model-informed precision dosing of vancomycin in clinical practice: an intervention development study

Plasma effects on bacterial time-kill dynamics: Insights from a PK/PD modelling analysis

Therapeutic drug monitoring (TDM) of β-lactam/β-lactamase inhibitor (BL/BLI) drug combinations: insights from a pharmacometric simulation study

Ceftazidime-avibactam (CAZ-AVI) pharmacokinetics in critically ill patients undergoing continuous venovenous hemodiafiltration (CVVHDF)

PKPD modelling and simulation of longitudinal meropenem in vivo effects against Escherichia coli and Klebsiella pneumoniae strains with high MIC

Model-based translation of results from in vitro to in vivo experiments for afabicin activity against Staphylococcus aureus

Physiologically-based pharmacokinetic modelling in sepsis: A tool to elucidate how pathophysiology affects meropenem pharmacokinetics

Model‐based assessment of neutrophil‐mediated phagocytosis and digestion of bacteria across in vitro and in vivo studies

Synergy of polymyxin B and minocycline against KPC-3- and OXA-48-producing <i>Klebsiella pneumoniae</i> in dynamic time–kill experiments: agreement with <i>in silico</i> predictions

Risk factors for and preventability of drug-related hospital revisits in older patients: A post-hoc analysis of a randomized clinical trial

Changes in critical inhaler technique errors in inhaled COPD treatment – A one-year follow-up study in Sweden

Changes in critical inhaler technique errors in inhaled COPD treatment - A one-year follow-up study in Sweden

Population pharmacokinetics of cefotaxime in intensive care patients

Population pharmacokinetics of cefotaxime in intensive care patients

Changes in critical inhaler technique errors in inhaled COPD treatment - a one-year follow-up study in Sweden

Continuous infusion of piperacillin-tazobactam significantly improves target attainment in children with cancer and fever

Imitation of beta-lactam binding enables broad-spectrum metallo-beta-lactamase inhibitors

Research priorities towards precision antibiotic therapy to improve patient care

Collaborators (5)

Jon Ulf Hansen

Thomas Tängdén

Vincent ARANZANA-CLIMENT

Lena Friberg

Anouk Muller

Make your next move.